Pages that link to "Q48590320"
Jump to navigation
Jump to search
The following pages link to Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP (Q48590320):
Displaying 50 items.
- Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines (Q23923841) (← links)
- A key amino acid responsible for substrate selectivity of monoamine oxidase A and B (Q28238919) (← links)
- Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data (Q31108497) (← links)
- Benzylamine analog binding studies as probes of the substrate sites of monoamine oxidases A and B. (Q33538239) (← links)
- Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Q33641852) (← links)
- Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease (Q33789328) (← links)
- Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP ) analogs and their energized accumulation by mitochondria (Q34322151) (← links)
- MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP ) in mouse brain. (Q35069025) (← links)
- Liquid chromatographic–electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP ) in discrete regions of murine brain (Q35997651) (← links)
- Role of astrocytes in MPTP metabolism and toxicity (Q36349357) (← links)
- Pyridine Derivatives: Structure-Activity Relationships Causing Parkinsonism-Like Symptoms (Q36916051) (← links)
- Oxidative stress as a cause of Parkinson's disease (Q37003217) (← links)
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease (Q37045190) (← links)
- Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. (Q37785104) (← links)
- Clues to the mechanism underlying dopamine cell death in Parkinson's disease (Q38668883) (← links)
- MPTP effects on dopamine neurons (Q39548164) (← links)
- Aminium cation radical mechanism proposed for monoamine oxidase B catalysis: are there alternatives? (Q40372752) (← links)
- Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies (Q40437286) (← links)
- Oxidative stress in Parkinson's disease (Q40538595) (← links)
- The colorful past and bright future of monoamine oxidase research. (Q40960334) (← links)
- Glutamate and Parkinson's disease (Q41056504) (← links)
- Selective and nonselective effects of 1-methyl-4-phenylpyridinium on oxygen consumption in rat striatal and hippocampal slices (Q41161444) (← links)
- Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. (Q41484307) (← links)
- Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite. (Q41741720) (← links)
- Mechanism-based inactivation of monoamine oxidases A and B by tetrahydropyridines and dihydropyridines (Q42001415) (← links)
- Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode (Q42101200) (← links)
- Evidence for the one-electron oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP ). (Q42219419) (← links)
- Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP. (Q42504998) (← links)
- Inhibition of complex I by hydrophobic analogues of N-methyl-4-phenylpyridinium (MPP ) and the use of an ion-selective electrode to measure their accumulation by mitochondria and electron-transport particles (Q42824368) (← links)
- Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases (Q42853435) (← links)
- Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (Q42854990) (← links)
- Synthesis and biological evaluation of MAO-A selective 1,4-disubstituted-1,2,3,6-tetrahydropyridinyl substrates (Q44057937) (← links)
- Placental toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice (Q44671325) (← links)
- Synthesis and monoamine oxidase B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines (Q44868188) (← links)
- Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (Q45099160) (← links)
- Potential latent nitrogen mustard derivatives designed to target monoamine oxidase rich cells (Q45107956) (← links)
- 1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substrates (Q45110846) (← links)
- The Neurotoxin l-Methyl-4-Phenyl-l,2,3,6-Tetrahydropyridine (MPTP): A Key to Parkinson's Disease? (Q46070690) (← links)
- Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures (Q46198074) (← links)
- Oxidation of tertiary amines by monoamine oxidases (Q46943715) (← links)
- Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B. (Q48093061) (← links)
- Monoamine oxidase-B in astrocytes (Q48271571) (← links)
- Increased striatal lipid peroxidation after intracerebroventricular MPP administration to mice (Q48273713) (← links)
- Serotonergic conversion of MPTP and dopaminergic accumulation of MPP . (Q48452514) (← links)
- Quantitation of a mitochondrial DNA deletion in Parkinson's disease (Q48507765) (← links)
- Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). (Q48508068) (← links)
- Chronic exposure to Ro20-1724 protects dopaminergic neurons in vitro against the neurotoxic action of N-methyl-D-aspartate and 1-methyl-4-phenylpyridinium (Q48729263) (← links)
- Nigrostriatal Monoamine Oxidase A and B in Aging Squirrel Monkeys and C57BL/6 Mice (Q48770292) (← links)
- [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterization. (Q48958530) (← links)
- Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment (Q52064896) (← links)